Veracyte (VCYT) Cash from Financing Activities (2012 - 2026)
Veracyte (VCYT) posted quarterly Cash from Financing Activities of $4.1 million for Q2 2026, up 831.27% year-over-year from $444445.8 in Q2 2025, and up 162.44% on a QoQ basis from -$6.6 million in Q1 2026.
Veracyte (VCYT) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Veracyte has reported Cash from Financing Activities for 15 years, with the latest figure at $4.1 million in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at $4.1 million, up 831.27% year-over-year; the trailing twelve-month figure through Jun 2026 was $338000.0 (up 126.59% YoY), and the FY2025 annual result was -$4.2 million, down 186.09% from the prior year.
- Cash from Financing Activities rose to $4.1 million in Q2 2026, from -$6.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $10.3 million in Q3 2024 and troughed at -$6.6 million in Q1 2026.
- A 5-year average of $251277.8 and a median of $101500.0 in 2022 frame the typical range for Cash from Financing Activities.
- The widest annual swing landed in 2024, when Cash from Financing Activities surged 9253.64%; it then slumped 5045.45% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $93000.0 in 2022, then surged by 593.55% to $645000.0 in 2023, then slumped by 799.22% to -$4.5 million in 2024, then surged by 96.7% to -$149000.0 in 2025, then soared by 2877.85% to $4.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $4.1 million in Q2 2026, -$6.6 million in Q1 2026, and -$149000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.14 Mn |
| Jun 30, 2026 | 4.14 Mn |
| Mar 31, 2026 | -6.63 Mn |
| Mar 31, 2026 | -6.63 Mn |
| Dec 31, 2025 | -149,000.00 |
| Dec 31, 2025 | -149,000.00 |
| Sep 30, 2025 | 2.98 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | -566,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -6.48 Mn |
| Mar 31, 2025 | -6.48 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -864,000.00 |
| Mar 31, 2024 | -864,000.00 |